Fulcrum therapeutics signs exclusive global license agreement in rare hematology

Camp4 therapeutics grants exclusive rights to advance novel therapies for diamond-blackfan anemia camp4 therapeutics grants exclusive rights to advance novel therapies for diamond-blackfan anemia

FULC Ratings Summary

FULC Quant Ranking